ANRO stock results show that Alto Neuroscience beat analyst estimates for earnings per share the second quarter of 2024. More
Articles
MNR Stock Earnings: Mach Natural Resources Misses EPS, Misses Revenue for Q2 2024
MNR stock results show that Mach Natural Resources missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. More
RDZN Stock Earnings: Roadzen Misses EPS, Misses Revenue for Q1 2025
RDZN stock results show that Roadzen missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2025. More
ARMP Stock Earnings: Armata Pharmaceuticals Beats EPS for Q2 2024
ARMP stock results show that Armata Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024. More
BOLT Stock Earnings: Bolt Biotherapeutics Misses EPS, Beats Revenue for Q2 2024
BOLT stock results show that Bolt Biotherapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. More
ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q2 2024
ELVN stock results show that Enliven Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. More
GRTS Stock Earnings: Gritstone Bio Beats EPS, Misses Revenue for Q2 2024
GRTS stock results show that Gritstone Bio beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. More
